146 related articles for article (PubMed ID: 35465240)
1. Whole genome sequencing-based drug resistance predictions of multidrug-resistant
Mbelele PM; Utpatel C; Sauli E; Mpolya EA; Mutayoba BK; Barilar I; Dreyer V; Merker M; Sariko ML; Swema BM; Mmbaga BT; Gratz J; Addo KK; Pletschette M; Niemann S; Houpt ER; Mpagama SG; Heysell SK
JAC Antimicrob Resist; 2022 Apr; 4(2):dlac042. PubMed ID: 35465240
[TBL] [Abstract][Full Text] [Related]
2. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
[TBL] [Abstract][Full Text] [Related]
3. Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of
Kardan-Yamchi J; Kazemian H; Battaglia S; Abtahi H; Foroushani AR; Hamzelou G; Cirillo DM; Ghodousi A; Feizabadi MM
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32046149
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
Salaam-Dreyer Z; Streicher EM; Sirgel FA; Menardo F; Borrell S; Reinhard M; Doetsch A; Cudahy PGT; Mohr-Holland E; Daniels J; Dippenaar A; Nicol MP; Gagneux S; Warren RM; Cox H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0036421. PubMed ID: 34460307
[TBL] [Abstract][Full Text] [Related]
5. Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
Sun W; Gui X; Wu Z; Zhang Y; Yan L
BMC Infect Dis; 2022 May; 22(1):499. PubMed ID: 35624432
[TBL] [Abstract][Full Text] [Related]
6. Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
Mpagama SG; Houpt ER; Stroup S; Kumburu H; Gratz J; Kibiki GS; Heysell SK
BMC Infect Dis; 2013 Sep; 13():432. PubMed ID: 24034230
[TBL] [Abstract][Full Text] [Related]
7. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
[TBL] [Abstract][Full Text] [Related]
8. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
Ceyhan İ; Vezir S
Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China.
He W; Liu C; Liu D; Ma A; Song Y; He P; Bao J; Li Y; Zhao B; Fan J; Cheng Q; Zhao Y
J Glob Antimicrob Resist; 2021 Sep; 26():241-248. PubMed ID: 34214699
[TBL] [Abstract][Full Text] [Related]
10. Diversified lineages and drug-resistance profiles of clinical isolates of
Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
[TBL] [Abstract][Full Text] [Related]
11.
Rukmana A; Gozali C; Erlina L
Int J Microbiol; 2024; 2024():2037961. PubMed ID: 38469390
[TBL] [Abstract][Full Text] [Related]
12. Use of Whole-Genome Sequencing to Predict
Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
[TBL] [Abstract][Full Text] [Related]
13. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
14. Comparison of
Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
[TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant tuberculosis in Finland: treatment outcome and the role of whole-genome sequencing.
Korhonen V; Kivelä P; Haanperä M; Soini H; Vasankari T
ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36451847
[TBL] [Abstract][Full Text] [Related]
16. Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.
He W; Tan Y; Liu C; Wang Y; He P; Song Z; Liu D; Zheng H; Ma A; Zhao B; Ou X; Xia H; Wang S; Zhao Y
Microbiol Spectr; 2022 Feb; 10(1):e0154321. PubMed ID: 35171016
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
19. Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
Lopez B; Siqueira de Oliveira R; Pinhata JMW; Chimara E; Pacheco Ascencio E; Puyén Guerra ZM; Wainmayer I; Simboli N; Del Granado M; Palomino JC; Ritacco V; Martin A
J Antimicrob Chemother; 2019 Feb; 74(2):373-379. PubMed ID: 30358851
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
